Physician profile
Desiree Heim
NPI 1558769687
$4,845.96
in general payments reported to CMS, 2019-2025
14 companies · $955 in 2025
The $955 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $503 · 2022: $371 · 2023: $1,004 · 2024: $2,014 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,180 · Travel and Lodging: $734 · Education: $57.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,180.06 |
| Travel and Lodging | $733.97 |
| Education | $57.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,190.03 | 2023-2025 | Inspire |
| Novo Nordisk INC | $563.51 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $471.74 | 2022-2025 | |
| Harmony Biosciences LLC | $169.50 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $95.63 | 2023-2025 | Sunosi |
| Abbott Laboratories | $60.81 | 2021-2022 | |
| Abbvie INC. | $60.56 | 2021-2023 | |
| Antares Pharma, INC. | $55.99 | 2021-2022 | |
| Lilly USA, LLC | $46.94 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $44.09 | 2024-2025 | Lumryz |
| Astrazeneca Pharmaceuticals LP | $36.64 | 2022 | |
| Tandem Diabetes Care, INC. | $19.22 | 2021 | |
| Resmed Corp | $18.30 | 2024 | |
| Ibsa Pharma INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Heim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.